US Market Entry Architecture · For New Zealand Companies

Go in knowing

I help New Zealand founders test pricing, marketing, buyer assumptions, legal, and operating structure before they hire, spend, or scale the wrong plan when entering the US.

Book a US Market Entry Diagnostic

The US is either an opportunity or a trap. Which one depends entirely on the decisions you make before you commit capital to the move.

Read: 19 reasons New Zealand companies fail in the US →

OPERATOR CREDENTIALS

SCALING RECORD

$110M

ANNUAL REVENUE

GROWTH RANK

#2

FASTEST-GROWING US COMPANY, Inc. 5000

CAPITAL RAISED

$22M

RAISED FROM US VCS

Sean McGrail, Founder, Pivotal Catalyst — US market entry operator for New Zealand companies
Sean McGrail · Founder, Pivotal Catalyst
Pivotal Decisions: Who this is for

For New Zealand companies where entering the US market becomes a defining decision.

You have traction in New Zealand. The product works. The team delivers. Now the question is whether the model you built here can survive a market that is bigger, more expensive, and less forgiving.

Revenue

NZD $3M–$25M. Proven domestic traction and the financial capacity to fund a serious US move.

Stage

Years 2–10. Past early survival. Now facing the question of whether the US is the next logical market.

Business Type

Profitable B2B or B2C product or service businesses in New Zealand.

Where You Are Now

You have had early US interest. Then the questions got harder: pricing, channel strategy, first buyer, and margin structure. That is the point I designed this work for.

THE RIGHT FIT

Design the architecture before US execution begins. Go in knowing what will break before you commit resources to the move.

The Cost of Getting the First Move Wrong

Most NZ companies don't fail in the US because they lacked effort or ambition.

They fail because they started executing before they resolved the decisions the US punishes hardest: pricing, channel choice, customer acquisition economics, hiring sequence, and timing. The initial cost looks like hiring too early, choosing the wrong channel, mispricing the offer, burning cash on weak economics, and losing a year learning what should have been resolved before launch.

The deeper cost is strategic. The board and investors lose confidence. The domestic business gets distracted. Founder time gets consumed by motion instead of traction.

Expensive "learning"

A failed US entry can easily cost more than $500,000.

Premature hiring. Wrong pricing. Weak channel selection. Poor CAC assumptions. Lost founder time. Each one is recoverable. Together, they are not.

I give founders a reality check before those costs become irreversible.

Why Pivotal Catalyst

I find what breaks in your business model.

I don't confirm what will work in the US. I look for what will break. The diagnostic is a structural stress test, not a market study. I scaled Paint Nite to $110M across 250+ US markets, raised $22M from US investors, and I know where models crack under US economics. That operating experience is the lens. Not a framework. Not a research methodology.

$0 to $110M in four years.

I co-founded Paint Nite and grew it to $110M in annual revenue in four years by getting the hard decisions right early: pricing, channels, unit economics, sequencing, and what not to do yet.

Investor lens, not just operator instinct

As an angel investor, I have advised and mentored more than 20 startups across very different industries. That breadth sharpens pattern recognition — the ability to see which structural mistakes recur across different businesses and what breaks next if the wrong decision gets made. I have also raised capital from US investors and understand how expansion decisions are judged when institutional money is involved.

Based in New Zealand

Auckland-based. Available in person.

Engagements run remotely or face-to-face. Founder-led from first conversation to final deliverable.

GLOBAL CREDENTIAL

Edmund Hillary Fellow

Investor Fellow of the Edmund Hillary Fellowship.  a global fellowship for investors and entrepreneurs based in New Zealand.

SERVICES AND PRICING

One starting point. Two engagements.

Every client starts with the US Market Entry Diagnostic before deciding whether to proceed to the full six-week engagement.

US Market Entry Diagnostic — $10,000

Book a US Market Entry Diagnostic →

Twelve months executing the wrong plan in the US is harder to recover from than $10,000 spent finding the right one.

US Market Entry Diagnostic

$10,000

A paid decision session that identifies the most important commercial issue in your current US expansion thinking. You leave with a named finding and a direct answer on whether to go, delay, or redesign. If both sides decide to proceed, I credit the fee in full toward the US Market Entry Architecture Engagement.

US Market Entry Architecture Engagement

$75,000

A six-week founder-led engagement that resolves the commercial decisions required before resources are committed to US expansion. Covers first buyer, first channel, pricing logic, unit economics, operating structure, first-hire sequence, and go / no-go. The output is a US Market Entry Architecture Decision Pack. Board-ready · Defensible · Operational from day one.

Book a US Market Entry Diagnostic →
Why This Is Different

You have other options. Here is why they solve a different problem.

NZTE and government export support

Useful for access, introductions, and market information.

They do not resolve whether your commercial model survives US economics.

Big 4 and large consulting firms

Useful for research and broad market analysis.

Not designed for founder-level decisions on pricing, channel selection, sequencing, and first-move logic.

A US-based consultant or fractional hire

Gives you in-market presence. Presence is not architecture. Execution only helps if the underlying model is right.

Doing it internally

Often the first instinct of a capable founder. Also the easiest way to carry NZ assumptions into a market that punishes them.

Before you spend in the US, know what has to be true.

Start with a paid US Market Entry Diagnostic. You will leave with a named finding and a direct answer on whether to go, delay, or redesign.

Book a US Market Entry Diagnostic →